Amy Foreman-Wykert is an accomplished professional in the field of scientific communications, currently serving as Executive Director at Amgen with a focus on Inflammation. Foreman-Wykert has held various leadership roles at Amgen, including Director of Global Publications for both Cardiovascular and Neuroscience Therapeutic Areas, as well as Oncology. Prior experience includes a position as Medical Writer II at Kendle International and a Postdoctoral Research Associate role at UCLA. Foreman-Wykert earned a Bachelor of Science in Biology from Mount Saint Mary's University and a Doctor of Philosophy in Microbiology and Immunology from New York University.